Parkinsons Disease - Pipeline Review, H2 2015

Parkinsons Disease - Pipeline Review, H2 2015

Code: GMDHC7299IDB | Published: Dec-2015 | Pages: 838 | Global Markets Direct
Price :

* Required Fields



Parkinsons Disease - Pipeline Review, H2 2015


Global Markets Directs, Parkinsons Disease - Pipeline Review, H2 2015, provides an overview of the Parkinsons Diseases therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Parkinsons Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Parkinsons Disease and special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

AC Immune SA
Acelot, Inc.
Acorda Therapeutics, Inc.
Addex Therapeutics Ltd
Advinus Therapeutics Ltd.
Aeolus Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc.
Allergan Plc
Amabiotics SAS
Amarantus Bioscience Holdings, Inc.
American Gene Technologies International Inc.
Amicus Therapeutics, Inc.
Anavex Life Sciences Corp.
Angita B.V.
Antoxis Limited
APeT Holding BV
Aposense Ltd.
Araclon Biotech, S.L.
Arrien Pharmaceuticals, LLC
Bial - Portela & Ca, S.A.
Bio-Modeling Systems SAS
BioArctic Neuroscience AB
Biogen, Inc.
Bionature E.A. Ltd.
Biopharm GmbH
Biotie Therapies Corp.
BrainStorm Cell Therapeutics Inc.
CalAsia Pharmaceuticals, Inc.
Calico LLC
Cardax Pharmaceuticals, Inc.
Cell Cure Neurosciences, Ltd.
Cellceutix Corporation
CHA Bio & Diostech Co., Ltd.
Chipscreen Biosciences Ltd
Chronos Therapeutics Limited
Clera Inc.
Clevexel Pharma SAS
Contera Pharma ApS
Corium International, Inc.
Curemark, LLC
Cynapsus Therapeutics Inc.
D-Pharm Ltd.
Depomed, Inc.
DermaXon, LLC
Domain Therapeutics SA
Edison Pharmaceuticals, Inc.
Eli Lilly and Company
Euroscreen S.A.
Gardedam Therapeutics Inc.
Gene Solutions LLC
Genecode AS
Genentech, Inc.
Genervon Biopharmaceuticals, LLC
GenKyoTex S.A.
Genzyme Corporation
GliaCure Inc.
H. Lundbeck A/S
Harbor Therapeutics, Inc.
Heptares Therapeutics Limited
Herantis Pharma Plc
Hisamitsu Pharmaceutical Co., Inc.
Hua Medicine Ltd.
Huons Co., Ltd.
Impel NeuroPharma, Inc.
Intec Pharma ltd.
Integrative Research Laboratories Sweden AB
InterMed Discovery GmbH
International Stem Cell Corporation
Intra-Cellular Therapies, Inc.
Io Therapeutics, Inc.
Iproteos S.L.
Jeil Pharmaceutical Co., Ltd.
KineMed, Inc.
Kissei Pharmaceutical Co., Ltd.
Kyowa Hakko Kirin Co., Ltd.
Lead Discovery Center GmbH
Ligand Pharmaceuticals, Inc.
Living Cell Technologies Limited
Longevity Biotech, Inc
Luye Pharma Group Ltd.
M et P Pharma AG
MedGenesis Therapeutix Inc.
Merck & Co., Inc.
Merz Pharma GmbH & Co. KgaA
Metabolic Solutions Development Company, LLC
Minerva Neurosciences, Inc.
Mission Therapeutics Ltd
MitoDys Therapeutics Limited
Motac Neuroscience Limited
Netherlands Translational Research Center B.V.
Neuralstem, Inc.
Neuraltus Pharmaceuticals, Inc.
Neuren Pharmaceuticals Limited
NeuroDerm Ltd.
Neurodyn Inc.
NeuroNascent, Inc.
Neuronax SAS
NeurOp, Inc
Neuropore Therapies, Inc.
New World Laboratories, Inc.
Newron Pharmaceuticals S.p.A.
nLife Therapeutics, S.L.
Novartis AG
NsGene A/S
Omeros Corporation
Oncodesign SA
Ono Pharmaceutical Co., Ltd.
OPKO Health, Inc.
Orion Oyj
Oryzon Genomics S.A.
Osmotica Pharmaceutical Corp.
Oxford BioMedica Plc
Peptron, Inc.
Pfizer Inc.
Pharma Two B Ltd
PharmatrophiX, Inc.
Pharmicell Co., Ltd.
Pharnext SAS
Prana Biotechnology Limited
Prexton Therapeutics SA
Primary Peptides, Inc.
Promentis Pharmaceuticals, Inc.
Promius Pharma, LLC
Proteostasis Therapeutics, Inc.
ProteoTech, Inc.
Prothena Corporation Plc
QR Pharma, Inc.
Raptor Pharmaceutical Corp.
Reliance Life Sciences Pvt. Ltd.
RestorGenex Corporation
RhinoCyte, Inc.
SanBio, Inc.
Saneron CCEL Therapeutics, Inc.
Saniona AB
Sellas Inc.
Selvita SA
Serina Therapeutics, Inc.
Shire Plc
Sigma-Tau S.p.A.
SignPath Pharma Inc
Signum Biosciences, Inc.
SK Biopharmaceuticals Co., Ltd.
STATegics, Inc.
Stelic Institute & Co.
Synovo GmbH
Synthonics, Inc.
Takara Bio Inc.
Takeda Pharmaceutical Company Limited
TauRx Therapeutics Ltd.
Tautatis Incorporated
TechnoPhage SA
Teikoku Pharma USA, Inc.
Teva Pharmaceutical Industries Limited
Titan Pharmaceuticals, Inc.
Trevena, Inc.
TyrNovo Ltd.
uniQure N.V.
Varinel, Inc.
Vernalis Plc
VistaGen Therapeutics , Inc.
VivaCell Biotechnology Espana S.L.
Voyager Therapeutics, Inc.
Wellstat Therapeutics Corporation
Zenobia Therapeutics, Inc.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]

2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal

3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at


There are no reports matching the selection.

Browse similar reports by category:
Pharmaceuticals & Healthcare
Global Markets Direct

Our Clients